[Leish-l] FW: PRO/AH/EDR> Leishmaniasis, cutaneous, visceral - Israel (02)

[jeffrey shaw]

From: ProMED-mail <promed at promed.isid.harvard.edu>

Date: 2012/9/25
Subject: PRO/AH/EDR> Leishmaniasis, cutaneous, visceral - Israel (02)
To: promed-ahead-edr at promedmail.org


LEISHMANIASIS, CUTANEOUS, VISCERAL - ISRAEL (02)


************************************************

A ProMED-mail post

<http://www.promedmail.org>

ProMED-mail is a program of the

International Society for Infectious Diseases

<http://www.isid.org>



Date: Thu 20 Sep 2012

Source: Ynetnews

<http://www.ynetnews.com/articles/0,7340,L-4282121,00.html> [edited]





The Environmental Protection Ministry expressed concern over the

growing number of cutaneous leishmaniasis cases reported in over the

past year, and has been able to obtain NIS 10 million (roughly USD 2.6

million) in government funds to curb a potential outbreak. The funds

are to be allocated across 3 years.



The Health Ministry has reports of 293 patients in 2011 -- double the

number of cases reported in 2010.



According to the Environmental Protection Ministry's data, over 1650

people in 50 communities is Israel have contracted the Oriental sore

over the past decade, especially around the Sea of Galilee, the Judea

Mountains, the western Negev, the Arava, and the Beit Shean Valley.



Cutaneous leishmaniasis, commonly known as "Oriental sore," or "Aleppo

boil," is a skin infection caused by a single-celled parasite. It is

usually transmitted by sandflies.



The ministry appealed to the cabinet for funds meant to help at-risk

communities, in the form of setting up sandfly traps and building

fences to keep the rock hyrax -- which is a known carrier -- out.



"This is a difficult disease that has inflicted many and left them

scarred, literally," Environmental Protection Minister Gilad Erdan

said. "After years of ignoring this hazard, the government is taking

on dealing with this national infliction."



[Byline: Itay Gal]



--

Communicated by:

ProMED-mail

<promed at promedmail.org>



[_Leishmania tropica_ and _L. major_ causing cutaneous leishmaniasis

(CL) have been identified in jackals, foxes, and rock hyrax throughout

Israel (Talmi-Frank D et al: _Leishmania tropica_ infection in golden

jackals and red foxes, Israel. Emerg Infect Dis. 2010; 16(12): 1973-5;

<http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294571/> and Talmi-Frank

D et al: _Leishmania tropica_ in rock hyraxes (_Procavia capensis_) in

a focus of human cutaneous leishmaniasis. Am J Trop Med Hyg. 2010;

82(5): 814-8;

<http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861385/>).



CL has been slowly increasing in Israel at least over the past decade

(Vinitsky O et al: Geographic and epidemiologic analysis of the

cutaneous Leishmaniasis outbreak in northern Israel, 2000-2003. Isr

Med Assoc J. 2010; 12(11): 652-6;

<http://www.ncbi.nlm.nih.gov/pubmed/21243862>).



Visceral leishmaniasis, VL, caused by _Leishmania infantum_ has also

returned to Israel after being absent for 30 years, with dogs as the

main reservoir (Nasereddin A et al: Molecular fingerprinting of

_Leishmania infantum_ strains following an outbreak of visceral

leishmaniasis in central Israel. J Clin Microbiol. 2005; 43(12):

6054-9; <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1317210/> and

Hamarsheh O et al: Serological and molecular survey of _Leishmania_

parasites in apparently healthy dogs in the West Bank, Palestine.

Parasit Vectors. 2012; 5(1): 183;

<http://www.ncbi.nlm.nih.gov/pubmed/22937916>). - Mod.EP



A HealthMap/ProMED-mail map can be accessed at:

<http://healthmap.org/r/1z-1>.]



[see also:

Leishmaniasis, cutaneous - Israel 20120902.1277142

2011

----

Leishmaniasis, cutaneous - Israel 20110130.0362

2004

----

Leishmaniasis, cutaneous - Israel 20040125.0299]

.................................................sb/arn/ep/mj/jw

*##########################################################*

************************************************************

ProMED-mail makes every effort to  verify  the reports  that

are  posted,  but  the  accuracy  and  completeness  of  the

information,   and  of  any  statements  or  opinions  based

thereon, are not guaranteed. The reader assumes all risks in

using information posted or archived by  ProMED-mail.   ISID

and  its  associated  service  providers  shall not be  held

responsible for errors or omissions or  held liable for  any

damages incurred as a result of use or reliance upon  posted

or archived material.

************************************************************

Donate to ProMED-mail. Details available at:

<http://www.isid.org/ProMEDMail_Donations.shtml>

************************************************************

Visit ProMED-mail's web site at <http://www.promedmail.org>.

Send all items for posting to: promed at promedmail.org (NOT to

an individual moderator).  If you do not give your full name

name and affiliation,  it may not be posted.  You may unsub-

scribe at  <http://www.isid.org/promedmail/subscribe.lasso>.

For  assistance  from   a   human   being,   send  mail  to:

<postmaster at promedmail.org>.

############################################################

############################################################


 		 	   		  
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lineu.icb.usp.br/pipermail/leish-l/attachments/20120926/cc2f9553/attachment-0001.htm>